SP5030 |
SP5032 |
HSIF |
||
This peptide, LLRSSLILLQGSWF (LLRSSLILLQGSWFamide) is one of several endogenous peptides derived from proteins containing a conserved somatotropin domain and selected for inhibition of angiogenesis and lymphangiogenesis using in vitro proliferation, migration, adhesion and tube formation assays with blood and lymphatic endothelial cells (Lee et al, 2011). The peptide is derived from TMEM45A [transmembrane protein 45A] and corresponds to TMEM45A(181-194) [transmembrane protein 45A(181-194)].
The peptide inhibits the migration of human
...
...
...
...
... Subscribe to continue reading!
... ...
Content view restricted ! |